NewAmsterdam Pharma Company share price logo

NewAmsterdam Pharma Company

NASDAQ: NAMS

Mid Cap

$19.52

-2.06

(-9.57%)

Live

as on

NewAmsterdam Pharma Company Stock Performance

as on October 24, 2026 at 6:25 am IST

  • Day's Low

    Day's High

    $19.13
    $21.35
    downward going graph

    2.00%

    Downside

    9.38%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $19.58
    $42.21
    downward going graph

    -0.31%

    Downside

    116.21%

    Upside

    downward going graph

NewAmsterdam Pharma Company share price movements today

Previous Close
$21.58
Open
$21.35
Volume
1.7M
Market Cap
$2.5B
Day's Low - High
$19.13 - $21.35
52 Week Low - High
$19.58 - $42.21

NewAmsterdam Pharma Company Historical Returns

1 Month Return
-4.85 %
3 Month Return
-29.36 %
1 Year Return
-40.53 %
3 Year Return
+ 240.38 %
5 Year Return
0 %

NewAmsterdam Pharma Company Stock Fundamentals & Key Indicators

Check NewAmsterdam Pharma Company market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.5B

EPS (TTM)

-2.18

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-9.86

Industry PE ratio

-10.60

PEG Ratio

0.29

EBITDA

-254.9M

Revenue (TTM)

7.1M

Profit Margin

92.15%

Return On Equity TTM

-38.33%

NewAmsterdam Pharma Company vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NewAmsterdam Pharma Company with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NewAmsterdam Pharma Company image
NewAmsterdam Pharma Company
StrongBuy$2.5BNA-9.8692.15%0.00%
Moderna image
Moderna
Neutral$98.1B-37.95%-30.80-12.57%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$44.0BNA27.4787.82%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.9B191.61%30.2886.04%0.00%
Regeneron image
Regeneron
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for NewAmsterdam Pharma Company Stock including INR - Dollar returns

The NewAmsterdam Pharma Company stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

NewAmsterdam Pharma Company investment value today

Current value as on today

₹58,185

Returns

-₹41,815

(-41.81%)

Returns from NewAmsterdam Pharma Company Stock

-₹46,204 (-46.2%)

Dollar Impact

₹4,389 (+4.39%)

Analyst Recommendation on NewAmsterdam Pharma Company Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for NewAmsterdam Pharma Company. Average target price of $49.9

NewAmsterdam Pharma Company Share Price Target

Get share price movements and forecasts by analysts on NewAmsterdam Pharma Company.

What analysts predicted

60.88%UPSIDE

Target Price

$49.9

Current Price

$19.52

Analyzed by

7 Analysts

High

$60

Target

$49.90

Low

$42

NewAmsterdam Pharma Company target price $49.9, a slight upside of 60.88% compared to current price of $19.52. According to 7 analysts rating.

Indian Investors' Interest in NewAmsterdam Pharma Company Stock

Search interest for NewAmsterdam Pharma Company Stock has increased by 154% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:154% versus previous 30 day period

NewAmsterdam Pharma Company Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
2
29
12
2
19
0
0
3
3
Gross Profit
1
2
29
12
2
19
0
0
2
3
Operating Income
-54
-52
-25
-43
-68
-35
-55
-65
-58
-64
EBITDA
-54
-51
-23
-111
-39
-17
-71
-74
-48
-59
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-93
-39
-16
-92
-39
-17
-72
-74
-48
-64
Income Tax Expense
-
-
0
-
-
-
-
-
-
-
Net Income
-93
-39
-16
-92
-39
-17
-72
-74
-48
-64
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
-84.38%
83.55%
100.00%

NewAmsterdam Pharma Company Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
102
14
45
22
Gross Profit
-
-
102
14
45
22
Operating Income
-6
-34
-3
-182
-176
-225
EBITDA
-6
-41
-22
-176
-241
-242
Interest Expense
-
0
0
6
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-7
-41
-22
-176
-241
-203
Income Tax Expense
-
-
-
0
0
-
Net Income
-7
-41
-22
-176
-241
-203
Net Profit Margin
0.00%
0.00%
100.00%
100.00%
100.00%
99.74%

NewAmsterdam Pharma Company Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-93
-39
-16
-92
-39
-17
39
-74
-48
-64
Operating Cash Flow
-54
-53
-12
-37
-36
-37
-32
-40
-30
-39
Investing Cash Flow
0
0
0
-62
2
-159
2
-21
-11
-4
Financing Cash Flow
198
4
0
456
6
3
5
13
11
11
Change in Cash
140
-50
-7
349
-23
-184
-24
-48
-32
-33

NewAmsterdam Pharma Company Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-41
-22
-176
-241
-203
Operating Cash Flow
-7
-29
10
-141
-158
-147
Investing Cash Flow
0
0
0
0
-62
-174
Financing Cash Flow
13
84
391
8
659
29
Change in Cash
6
50
407
-127
431
-280

Global Institutional Holdings in NewAmsterdam Pharma Company

Check out the Institutions with significant holdings in NewAmsterdam Pharma Company.

Funds
Holdings
Peter Kolchinsky
7.99%
SMALLCAP World Fund Inc
7.02%
James E. Flynn
3.57%
Andreas Halvorsen
3.52%
VANGUARD SPECIALIZED FUNDS
2.87%
See all

NewAmsterdam Pharma Company News & Key Events

    Insights on NewAmsterdam Pharma Company

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 7 days, NAMS stock has moved up by 8.8%

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 3 quarters, 32.0K → 3.70M (in $), with an average increase of 58.4% per quarter

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, NAMS has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 712.4%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, -48.44M → -64.13M (in $), with an average decrease of 32.4% per quarter

    About NewAmsterdam Pharma Company

    NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer’s disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
    OrganisationNewAmsterdam Pharma Company
    HeadquartersGooimeer 2-35, Naarden, NH, 1411 DC, NL
    IndustryBiotechnology
    CEOMichael Harvey Davidson Facp.

    Key Management of NewAmsterdam Pharma Company

    Name

    Title

    Mr. Robert W. Gunning CPA, CGMA

    Principal Accounting Officer, VP & Controller

    Mr. Michael F. Marino Esq.

    Chief Legal Officer & Corporate Secretary

    Ms. Maryellen McQuade

    Chief People Officer

    Ms. Juliette Audet M.B.A., M.Sc.

    Chief Strategy & Business Officer

    Dr. Marc Ditmarsch M.D.

    Chief Development Officer

    Dr. Michael Harvey Davidson FACC, Facp., M.D.

    CEO, President & Executive Director

    Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D.

    Founder, Chief Scientific Officer, Member of Executive Board & Director

    Mr. Mayur Amrat Somaiya

    Chief Financial Officer

    Mr. Matthew Philippe

    Executive VP & Head of Investor Relations

    Mr. Chris Deluzio

    Executive Vice President of Sales Enterprise Operations

    FAQs

    What is NewAmsterdam Pharma Company share price today?

    NewAmsterdam Pharma Company share price today is $19.52 as on . NewAmsterdam Pharma Company share today touched a day high of $21.35 and a low of $19.13.

    What is the 52 week high and 52 week low for NewAmsterdam Pharma Company share?

    NewAmsterdam Pharma Company share touched a 52 week high of $42.21 on and a 52 week low of $19.58 on . NewAmsterdam Pharma Company stock price today i.e. is trending at $19.52,which is 53.75% down from its 52 week high and -0.31% up from its 52 week low.

    What is NewAmsterdam Pharma Company's market capitalisation today?

    NewAmsterdam Pharma Company market capitalisation is $0.00T as on .

    How to invest in NewAmsterdam Pharma Company Stock (NAMS) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for NewAmsterdam Pharma Company on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy NewAmsterdam Pharma Company Stock (NAMS) from India?

    Indian investors can start investing in NewAmsterdam Pharma Company (NAMS) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.40 in NewAmsterdam Pharma Company stock (as per the Rupee-Dollar exchange rate as on ). Based on NewAmsterdam Pharma Company share’s latest price of $19.52 as on October 24, 2026 at 12:55 am IST, you will get 0.5123 shares of NewAmsterdam Pharma Company. Learn more about fractional shares .